Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway-Science-Chemical Encyclopedia-lookchem

Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway
Add time:07/25/2019 Source:sciencedirect.com

AimsTo evaluate the therapeutic benefits of Hesperidin (Hes) using an imiquimod (IMQ)-induced psoriasis-like mouse model and human immortalized keratinocytes (HaCaT) cells stimulated with lipopolysaccharide (LPS).

We also recommend Trading Suppliers and Manufacturers of IRS 19 (cas 112444-82-3). Pls Click Website Link as below: cas 112444-82-3 suppliers

Prev:Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action
Next: IRS and corporate taxpayer effects of geographic proximity)

Click to view details

Health and Chemicalmore >